Matrix metallopeptidase 1 mRNA (MMP1 mRNA) (MMP1 mRNA)

Matrix metallopeptidase 1 (MMP1) mRNA is the transcript responsible for the synthesis of the MMP1 enzyme, also known as interstitial collagenase (NCBI Gene ID: 4312). This enzyme is a member of the zinc-dependent endopeptidase family and is primarily involved in the degradation of Type I, II, and III collagens, which are major components of the extracellular matrix (UniProt P03956). In healthy tissues, MMP1 mRNA expression is induced during processes like wound healing and tissue remodeling, but its chronic overexpression is associated with pathological states such as rheumatoid arthritis, osteoarthritis, and cancer metastasis (PubMed: 25605961). Therapeutic strategies targeting MMP1 mRNA utilize RNA interference (RNAi) and antisense oligonucleotides to reduce the levels of the MMP1 protein, thereby preventing excessive tissue destruction and tumor cell invasion (PubMed: 15103347). While most MMP1-targeting RNA therapeutics are currently in the preclinical or experimental stage, they represent a precise method for modulating collagenolytic activity compared to broad-spectrum small molecule inhibitors (PubMed: 11063268). Furthermore, monitoring MMP1 mRNA levels serves as a valuable biomarker for assessing disease progression and the efficacy of anti-collagenolytic therapies in clinical research.

Other names

Interstitial collagenase mRNAFibroblast collagenase mRNACLG mRNAMatrix metalloproteinase-1 mRNAMMP-1 mRNA

Inhibition of translation or induction of mRNA degradation via RNA interference (RNAi) or antisense mechanisms.